Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+1.74M
-
Total reported value, excl. options
-
$189M
-
Value change
-
+$26.5M
-
Number of buys
-
28
-
Number of sells
-
-17
-
Price
-
$15.31
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q4 2021
53 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q4 2021.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 55M outstanding shares and own 22.08% of the company stock.
Largest 10 shareholders include Hudson Executive Capital LP (2.4M shares), Blue Water Life Science Advisors, LLC (1.71M shares), Board of Trustees of The Leland Stanford Junior University (1.63M shares), Polar Capital Holdings Plc (1.32M shares), BlackRock Inc. (766K shares), VANGUARD GROUP INC (675K shares), MILLENNIUM MANAGEMENT LLC (585K shares), Allspring Global Investments Holdings, LLC (489K shares), VR Adviser, LLC (400K shares), and FRED ALGER MANAGEMENT, LLC (273K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.